Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis
Frontiers in Pharmacology · 01.04.2026 · 17
DOI: 10.3389/fphar.2026.1790866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.04.2026. Verfasst von Fei He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Akkermansia muciniphila (AKK) is a potential probiotic. Our previous studies have shown that it could alleviate depressive-like behaviors (DLBs) in mice by inhibiting neuroinflammation in brain. To further explore its antidepressant effect, this study focused on the effects of AKK on the metabolic activities in gut-brain axis.
Methods
After chronic restraint stress (CRS) depression model was successfully built, AKK was used as intervention method for 3 weeks. The gut microbiome in feces and two intestinal permeability proteins in colon (Claudin-1, Occludin) were measured, and the metabolites in feces, colon, liver, and prefrontal cortex were also measured. In addition, two inflammation-related factors in hippocampus (Free fatty acid receptors 3 (FFAR3), phosphorylated NF-κB p65 (p-p65)) were measured.
Results
AKK was successfully colonized in gut of chronic restraint stress (CRS) mice. The DLBs in CRS mice receiving AKK (CRS + AKK) were significantly improved, along with the improved gut microbiome. Both Claudin-1 and Occludin in colon were significantly increased in CRS + AKK mice compared to CRS mice receiving phosphate buffer saline (PBS) (CRS + p). Metabolomics analysis indicated that AKK could significantly improve the changed lipids and lipid-like molecules in gut-brain axis of CRS mice; and function analysis using differential metabolites showed that AKK could significantly improve the disordered glycerophospholipid metabolism in feces, colon, liver, and prefrontal cortex of CRS mice. Additionally, we found that FFAR3 and phosphorylated NF-κB p65 were increased and decreased, respectively, in hippocampus of CRS + AKK mice compared to CRS + p mice.
Conclusion
Our results suggested that AKK might improve the disturbances of gut microbiome, intestinal permeability, host’s lipid metabolism and inflammation levels in hippocampus. Glycerophospholipid metabolism in gut-brain axis might be the important mediator in the process of AKK producing antidepressants effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Emergency Medicine, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing, China.
- Department of Neurology, National Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zitieren
APA
He, F., Bai, S., Xie, J., Zhang, Y., Xu, K., Wang, J., Ren, Y., Ren, Z., Chen, J., Wang, Y., & Xie, P. (2026). Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1790866
Vancouver
He F, Bai S, Xie J, Zhang Y, Xu K, Wang J, et al. Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1790866
BibTeX
@article{He2026,
author = {He, Fei and Bai, Shunjie and Xie, Jing and Zhang, Yongzhi and Xu, Ke and Wang, Jiaolin and Ren, Yi and Ren, Zhe and Chen, Jianjun and Wang, Ying and Xie, Peng},
title = {Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1790866}
}
EUVIMED